Nestlé Research Center, 1000 Lausanne, Switzerland.
Department of Epidemiology, Julius Center for Health Sciences and Primary Care, UMC Utrecht, 3508 GA Utrecht, The Netherlands.
Nutrients. 2018 Jul 19;10(7):920. doi: 10.3390/nu10070920.
Chronic constipation (CC) remains a common gastrointestinal (GI) disorder that conveys a substantial healthcare burden. Expert guidelines recommend increasing fiber intake, yet the clinical evidence to support this needs strengthening for specific fibers. The aim was to evaluate changes in intestinal transit time and GI symptoms in CC patients who consumed polydextrose. In a randomized, double-blind, placebo-controlled trial, 128 adults with CC received 8 g or 12 g polydextrose, or placebo, daily for 4 weeks. Transit time, as primary outcome, was assessed by radiopaque marker distribution after 2-weeks intervention. Bowel habits, GI symptoms and quality of life (QOL) were assessed by questionnaire, including the Patient-Assessment of Constipation (PAC) Symptoms (SYM), and PAC-QOL. Following 2-weeks intervention, no reduction was seen in transit time in any group and following 2- or 4-weeks intervention, no improvements were seen in stool frequency or consistency in any group. After 2-weeks intervention with 8 g/day polydextrose an improvement was seen in the PAC-SYM rectal score ( = 0.041). After 4-weeks intervention both rectal ( = 0.049) and stool ( = 0.029) scores improved while improvement in the QOL satisfaction score did not reach significance ( = 0.071). Overall, the results suggest that 2-weeks consumption of 8 or 12 g/day polydextrose does not significantly improve physiological measures of gut function in CC adults. Longer term consumption may improve clinical measures, but further studies will be required to substantiate this.
慢性便秘(CC)仍然是一种常见的胃肠道(GI)疾病,会给医疗保健带来很大的负担。专家指南建议增加膳食纤维的摄入量,但支持这一建议的临床证据需要针对特定纤维进行加强。本研究旨在评估 CC 患者摄入聚右旋糖后肠道转运时间和胃肠道症状的变化。在一项随机、双盲、安慰剂对照试验中,128 名 CC 成年人每天接受 8 克或 12 克聚右旋糖或安慰剂治疗 4 周。通过在干预 2 周后评估不透射线标志物的分布来评估转运时间,这是主要结果。通过问卷评估肠道习惯、胃肠道症状和生活质量(QOL),包括患者便秘评估(PAC)症状(SYM)和 PAC-QOL。在 2 周的干预后,任何组的转运时间都没有减少,在 2 或 4 周的干预后,任何组的粪便频率或稠度都没有改善。在每天 8 克聚右旋糖治疗 2 周后,PAC-SYM 直肠评分有所改善(=0.041)。在 4 周的干预后,直肠(=0.049)和粪便(=0.029)评分均有所改善,而 QOL 满意度评分的改善未达到显著水平(=0.071)。总体而言,结果表明,2 周内每天摄入 8 克或 12 克聚右旋糖不会显著改善 CC 成年人肠道功能的生理测量指标。长期摄入可能会改善临床测量指标,但需要进一步的研究来证实这一点。